Navigation Links
Rensselaer Polytechnic Institute professor Peter M. Tessier named Pew Scholar
Date:6/17/2010

Troy, N.Y. Peter M. Tessier, assistant professor of chemical and biological engineering at Rensselaer Polytechnic Institute, has been named a 2010 Pew Scholar in the Biomedical Sciences by the Pew Charitable Trusts.

The distinction includes an award of $240,000 over four years and inclusion into a select community of scientists that includes three Nobel Prize winners, three MacArthur Fellows, and two recipients of the Albert Lasker Medical Research Award, according to the Pew Charitable Trusts.

"We congratulate Dr. Tessier for being selected as a Pew Scholar in Biomedical Sciences, an honor reserved for the most promising young faculty in the biomedical field," said David Rosowsky, dean of the School of Engineering at Rensselaer. "We are extremely proud of Peter for being named a Pew Scholar as well as his recent CAREER Award from the National Science Foundation and we look forward to his continued development as a leading scholar and researcher. Dr. Tessier's recent recognitions are further evidence of the very high caliber of faculty we are attracting to Rensselaer."

Tessier joined the Rensselaer faculty in 2007 following a postdoctoral fellowship at the Massachusetts Institute of Technology's Whitehead Institute for Biomedical Research. He received his bachelor's degree in chemical engineering from the University of Maine, and went on to earn his doctoral degree in chemical engineering from the University of Delaware.

Tessier is investigating fundamental aspects of misfolding and clumping of three classes of proteins, long strings of molecules that participate in virtually every cellular process. Proteins fold into complex, three-dimensional structures, which is required for their proper function. Defects in the folding process can occur, which creates toxic protein clumps that are the basis of disorders ranging from Alzheimer's disease to glaucoma.

Tessier's immediate goal is to understand how the incorrect processing of proteins can be prevented, reversed, or redirected. His long-term objective is to develop new therapies to treat diseases related to toxic protein aggregation.

The Pew Scholars program enables scientists to take calculated risks, expand their research, and explore unanticipated leads. According to Pew, the program now in its 25th year has invested more than $125 million to fund nearly 500 scholars. Many of the nation's best early-career scientistsworking in all areas of physical and life sciences related to biomedical researchapply to the rigorously competitive program. Applicants are nominated by one of 155 invited institutions and demonstrate excellence and innovation in their research.

"Twenty-five years ago, the Pew Charitable Trusts identified a tremendous opportunity to impact the world of science by supporting the most promising young investigators and encouraging them to pursue their best ideas without restrictions," said Rebecca W. Rimel, president and CEO of the Pew Charitable Trusts. "Motivating scientists at this point in their careers is essential to advancing discovery and innovation, and Pew is honored to continue its commitment to this cadre of high-quality researchers."

Earlier this year, Tessier was also awarded a five-year, $411,872 Faculty Early Career Development Award (CAREER) from the National Science Foundation (NSF) to further his research into protein thermodynamics and aggregation.


'/>"/>

Contact: Mary Martialay
martialay@earthlink.net
518-276-2176
Rensselaer Polytechnic Institute
Source:Eurekalert

Related biology news :

1. Rensselaer Polytechnic Institute professor Patrick Underhill receives NSF CAREER award
2. Rensselaer Polytechnic Institute wins $2.45 million grant to support stem cell research
3. Rensselaer researchers to send bacteria into orbit aboard space shuttle Atlantis
4. Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals
5. Rensselaer receives more than $2 million from New York State to fund stem cell research
6. Trustee makes donation to start new solar energy research center at Rensselaer
7. Deadly dose: Rensselaer heparin expert helps uncover source of lethal contamination
8. Gladstone and Institute for Systems Biology collaborate on Huntingtons disease
9. National Eye Institute hosts Translational Research and Vision Symposium
10. University of Washington institute to get as much as $100 million to study atmosphere, ocean
11. Norwegian Institute of Public Health receives $100,000 Grand Challenges Explorations grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
Breaking Biology Technology: